Allogene Therapeutics, Inc. ($ALLO)
Filing Information
| Accession Number | 0001737287-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
234,685
Total Value
$7,167.24
P&L
+inf% (+$477,172.26)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Finance | Common Stock | โ | Feb 2, 2026 | Sale | 4,167 | $1.72 | $7,167.24 | 130,322 | Direct | โ | View Details | |
SVP, Finance | Stock Option (Right to buy) | Derivative | Feb 2, 2026 | Grant/Award | 179,691 | $0.00 | $0.00 | 179,691 | Direct | โ | View Details | |
SVP, Finance | Restricted Stock Unit | Derivative | Feb 2, 2026 | Grant/Award | 50,827 | $0.00 | $0.00 | 50,827 | Direct | โ | View Details |